Mucor/Rhizopus (Mucormycosis agents) in food: ingestion safety

(People-specific data is limited; this page draws from human adult context.) Mucor and Rhizopus species (order Mucorales) are the primary causative agents of mucormycosis (formerly zygomycosis), an aggressive, rapidly progressive fungal infection with 50% overall mortality. The COVID-19-associated mucormycosis (CAM) surge in India in 2021 was catastrophic: >45,000 cases reported, primarily rhino-orbito-cerebral mucormycosis in patients with diabetes, corticosteroid use, and recent SARS-CoV-2 infection. Key virulence: Mucorales have unique affinity for endothelial cells via the glucose-regulated protein 78 (GRP78) receptor; in hyperglycemic, acidotic conditions (diabetic ketoacidosis), free iron increases dramatically, promoting Mucorales growth (iron acquisition via rhizoferrin). Clinical forms: rhino-orbito-cerebral (most common, 40% mortality), pulmonary (60-80% mortality), cutaneous (trauma/burns), disseminated (>90% mortality), and gastrointestinal. Angioinvasion causes tissue necrosis (characteristic black eschar). Treatment requires ALL THREE: (1) surgical debridement of necrotic tissue, (2) high-dose amphotericin B (only effective antifungal — azoles are INEFFECTIVE), and (3) reversal of underlying predisposition (glycemic control, immunosuppression reduction). Isavuconazole is the only azole with Mucorales activity. Delay in treatment >6 days doubles mortality.